Medical News

RSS

BVA unveils wide-view neurostimulator concept, prototype bionic eye

Bionic Vision Australia today unveils their wide-view neurostimulator concept - a bionic eye that will be implanted into Australia's first recipient of the technology.

31 Mar 2010

Canon launches REALiS SX7 Mark II D with DICOM Simulation Mode

Canon U.S.A., Inc., a leader in digital imaging, today announced the latest addition to the award-winning REALiS Multimedia Projector lineup, the SX7 Mark II D with DICOM Simulation Mode. In the medical-education field viewing monochrome digital X-Rays, CAT Scans and MRI's with accurate color and precise detail is of the highest importance and the REALiS SX7 Mark II D is able to meet this need on a scale much larger than traditional monitors.

31 Mar 2010

Shareholders approve all resolutions at Coastal Contacts' annual general and special meeting

Coastal Contacts Inc. announces that shareholders overwhelmingly approved all resolutions brought before them at the Company's annual general and special meeting held on March 26, 2010 in Vancouver, Canada.

31 Mar 2010

Drinking orange juice with fast-food meal may help prevent vascular inflammation

Eating foods containing flavonoids -- orange juice, in this case -- along with a high-fat, high-carbohydrate fast-food meal neutralizes the oxidative and inflammatory stress generated by the unhealthy food and helps prevent blood vessel damage, a new study by University at Buffalo endocrinologists shows.

31 Mar 2010

Cell Therapeutics agrees to sell $20M of Series 4 Preferred Stock and warrants to institutional investors

Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell $20 million of shares of its Series 4 Preferred Stock and warrants to purchase shares of its common stock in a registered offering to three institutional investors.

31 Mar 2010

DNC Chairman commends Obama for signing historic health care bill

DNC Chairman Tim Kaine issued the following statement after President Obama signed the Health Care and Education Reconciliation Act. The bill, which authorizes the largest investment in higher education in American history, was passed by the House and Senate last week as part of the health care reform process.

31 Mar 2010

PolyMedix completes Phase 1B clinical study with PMX-30063 defensin-mimetic antibiotic

PolyMedix, Inc., an emerging bio-technology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a Phase 1B clinical study with its novel defensin-mimetic antibiotic, PMX-30063. The data from the study demonstrate that administration of multiple doses of PMX-30063 are safe and well-tolerated at dose levels which showed bactericidal activity in blood samples drawn from subjects in the study.

31 Mar 2010

Despite stagnant economy, total employment in Ohio's bioscience sector increased by 2.8%

Employment in Ohio's biosciences sector is on the rise across the state according to a report released today by BioOhio, a non-profit organization supported by the Thomas Edison Program of the Ohio Department of Development.

31 Mar 2010

HCCMIS nominated for 2010 Techpoint Mira Awards

HCC Medical Insurance Services, LLC received a nomination for the 2010 Techpoint Mira Awards. In its 11th year, the Mira Awards acknowledge advancements made by organizations and individuals in technology-related industries.

31 Mar 2010

Likeley CMS pick Berwick has big ideas on fixing U.S. health care delivery

Dr. Donald Berwick is reportedly the president's choice to run the Centers for Medicare and Medicaid.

31 Mar 2010

Plan to convert 6 Mass. charity hospitals to for-profit - a model for other areas?

The New York private equity firm that last week struck a deal to buy Caritas Christi Health Care could build the chain of six Catholic community hospitals into a competitive lower-cost provider of medical services in Massachusetts, touting it as a profitable national business model in the age of health care reform, analysts say.

31 Mar 2010

PMDD often misdiagnosed as major depression or other mood disorder

As science slowly, but continually, unravels the causes of disorders, it increasingly teases apart biological threads that, when spooled together, begin to take on the warp and weft of separate disorders.

31 Mar 2010

Dr. Ingmar Bruns selected as seventh recipient of EHA-ASH Research Exchange Award

The European Hematology Association and the American Society of Hematology have selected Ingmar Bruns, MD, as the seventh recipient of the EHA-ASH Research Exchange Award, which serves to strengthen ties between North American and European scientific communities.

31 Mar 2010

BioSante Pharmaceuticals completes Azur Pharma Elestrin royalty buydown

BioSante Pharmaceuticals, Inc. today announced the successful completion of the Azur Pharma Elestrin royalty buydown, and financial results for the year ended December 31, 2009.

31 Mar 2010

U.S. hotel offers personalized menus for children with food allergies

Traveling and dining with a young child with food allergies or special dietary needs can be a nightmare as most restaurants and hotels are not sensitive to this epidemic affecting more than three million children - one in 17 for those under age 3 - in the U.S. Lake Arrowhead Resort and Spa now offers personalized menus for guests' children on restricted diets to make them feel special, not different.

31 Mar 2010

How the overhaul will affect insurance premiums for three key groups

One looming question for many consumers is whether the health overhaul will change how much they pay for insurance. Reports explore how the legislation will affect insurance premiums for three different groups.

31 Mar 2010

AgaMatrix, sanofi-aventis announce long-term partnership for BGM solutions

AgaMatrix, Inc. and sanofi-aventis today announced that they have signed a long-term agreement for the development, supply and commercialization of blood glucose monitoring (BGM) solutions. Under the terms of the agreement, AgaMatrix and sanofi-aventis will co-develop innovative solutions in diabetes management that incorporate AgaMatrix's WaveSense™ technology. Sanofi-aventis will commercialize through its Global Diabetes Division such integrated solutions for patients with diabetes, along with current sanofi-aventis insulins and delivery devices.

31 Mar 2010

Astellas Pharma extends all-cash tender offer of OSI Pharmaceuticals

Astellas Pharma Inc. announced today that it has extended its all-cash tender offer for $52 per share for all of the currently outstanding shares of common stock (including the associated stock purchase rights) of OSI Pharmaceuticals to 11:59 p.m. New York City time on Friday, April 23, 2010, unless further extended.

31 Mar 2010

Roche Diagnostics' CoaguChek XS Plus system granted CLIA-waived status

Roche Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted CLIA-waived status to the CoaguChek® XS Plus system, a point-of-care anticoagulation monitor that offers connectivity and data management tools to help healthcare professionals manage PT/INR (blood clotting time) testing.

From Roche Sequencing and Life Science 31 Mar 2010

Tips for avoiding ID theft while buying a home

IdentityTruth, the leading provider of a new breed of identity theft monitoring services to help consumers avoid identity theft and safeguard their privacy and identity, today is sharing its tips for avoiding ID theft when buying a home.

31 Mar 2010